Redwood Pharma AB (publ) has been invited to the BIO 2016 conference to present Redwood Pharma’s drug candidate RP101 and drug delivery platform IntelliGel®. BIO 2016 is the world’s largest conference on biotech. The conference takes place in San Francisco, CA, USA between June 6 to 9.
Over 15,000 participants will meet in San Francisco to among other things learn about trends and exchange ideas in different areas of biotech, life sciences and about new companies with innovative development projects. BIO is the world’s largest trade association in biotech representing biotech companies, academic institutions, etc. from the United States and over 30 other countries (www.bio.org).
“BIO organizes the largest biotech conference in the world. This year the organizers invited Redwood Pharma to present the company. This is a fantastic opportunity for us to highlight Redwood Pharma and our unique technology for treating chronic dry eye and drug delivery platform IntelliGel® “, says CEO Martin Vidaeus.
For further information:
Martin Vidaeus – CEO, Telephone: +46 70 232 29 29
E-mail: martin.vidaeus@redwoodpharma.se